The TIMELESS effort for timely DNA replication and protection

Accurate replication of the genome is fundamental to cellular survival and tumor prevention. The DNA replication fork is vulnerable to DNA lesions and damages that impair replisome progression, and improper control over DNA replication stress inevitably causes fork stalling and collapse, a major source of genome instability that fuels tumorigenesis. The integrity of the DNA replication fork is maintained by the fork protection complex (FPC), in which TIMELESS (TIM) constitutes a key scaffold that couples the CMG helicase and replicative polymerase activities, in conjunction with its interaction with other proteins associated with the replication machinery. Loss of TIM or the FPC in general results in impaired fork progression, elevated fork stalling and breakage, and a defect in replication checkpoint activation, thus underscoring its pivotal role in protecting the integrity of both active and stalled replication forks. TIM is upregulated in multiple cancers, which may represent a replication vulnerability of cancer cells that could be exploited for new therapies. Here, we discuss recent advances on our understanding of the multifaceted roles of TIM in DNA replication and stalled fork protection, and how its complex functions are engaged in collaboration with other genome surveillance and maintenance factors.

Automated summary

Accurate replication of the genome is crucial for cellular survival and tumor prevention. The DNA replication fork is susceptible to DNA lesions and damages that hinder its progression, leading to genome instability and tumorigenesis. The fork protection complex (FPC), particularly TIMELESS (TIM), plays a vital role in safeguarding the integrity of both active and stalled replication forks. Understanding TIM's multifaceted functions in DNA replication and stalled fork protection, as well as its collaboration with other genome surveillance factors, provides insights for potential therapies targeting replication vulnerability in cancer cells.